Health condition monitoring set
    2.
    外观设计

    公开(公告)号:USD1032850S1

    公开(公告)日:2024-06-25

    申请号:US29870316

    申请日:2023-01-20

    摘要: FIG. 1 is an isometric view of an embodiment of the health condition monitoring set;
    FIG. 2 is a front view thereof;
    FIG. 3 is a rear view thereof;
    FIG. 4 is a top view thereof;
    FIG. 5 is a bottom view thereof;
    FIG. 6 is a right side view thereof; and,
    FIG. 7 is a left side view thereof.

    ANTI-EPHA4 ANTIBODY
    7.
    发明公开
    ANTI-EPHA4 ANTIBODY 审中-公开

    公开(公告)号:US20230357386A1

    公开(公告)日:2023-11-09

    申请号:US18027413

    申请日:2021-12-22

    IPC分类号: C07K16/28 C12N15/63

    摘要: Provided is an anti-EphA4 antibody capable of binding to EphA4 and enhancing the cleavage of EphA4, and a pharmaceutical composition comprising the antibody as an active ingredient. The anti-EphA4 antibody comprises a heavy chain comprising a heavy chain CDR1 of SEQ ID NO: 30; a heavy chain CDR2 of SEQ ID NO: 31; and a heavy chain CDR3 of SEQ ID NO: 32; and a light chain comprising a light chain CDR1 of SEQ ID NO: 33; a light chain CDR2 of SEQ ID NO: 34; and a light chain CDR3 of SEQ ID NO: 35, or a heavy chain comprising a heavy chain CDR1 of SEQ ID NO: 42; a heavy chain CDR2 of SEQ ID NO: 31; and a heavy chain CDR3 of SEQ ID NO: 43; and a light chain comprising a light chain CDR1 of SEQ ID NO: 44; a light chain CDR2 of SEQ ID NO: 34; and a light chain CDR3 of SEQ ID NO: 35.